Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
DASON secures 800 million won in funding from the TIPS Program to develop next-generation wound dressing materials, improving commercialization opportunities.
Aug 07, 2026•2 days ago
South KoreaManufacturingBiotechnologyHealth CareMedicalMedical Device
Description
DASON, a South Korean medical startup, has been selected for the TIPS program, receiving 800 million won for R&D funding. This funding will support the development of self-moisture-regulating wound dressing materials. Additionally, DASON will participate in non-R&D programs for commercialization support. The TIPS selection was made on the recommendation of CCEI Jeju.
Company Information
Company
DASON
Location
South Korea
About
DASON is a South Korean startup specializing in medical-grade materials and medical device development. The company focuses on creating innovative wound dressing materials and has capabilities spanning material development to manufacturing and regulatory approval. Their products aim to enhance wound healing while reducing irritation and improving convenience for both patients and healthcare providers. DASON is expanding its reach into domestic and overseas markets including China and Japan.
South KoreaManufacturingBiotechnologyHealth CareMedicalMedical Device